BANGOR, Maine, Oct. 5 /PRNewswire-FirstCall/ -- Nyer Medical Group, Inc. today announced they are in negotiations to buy the remaining 20% interest in the Company’s 80% owned pharmacy subsidiary, D.A.W., Inc. (d/b/a Eaton Apothecary). A spokesperson for the Company stated, “There are no details on the negotiations at this time, but will be released once they become available.”
On October 4, 2005, Mark Dumouchel resigned as a member of the Company’s board of directors stating, “I believe that a conflict of interest may exist if I continue as a director of the Company. I am also a minority shareholder in D.A.W., Inc., therefore, I have decided to resign my position as a director of the Company to avoid this potential conflict.”
Nyer Medical Group, Inc. is a holding company that operates pharmacies in the greater Boston area and a medical products distribution business that distributes and markets medical equipment and supply products to hospitals, physicians and nursing homes using relationship-based telemarketing, direct sales personnel, catalogs and the Internet. These orders are filled by the Company’s distribution centers located in New England and South Florida.
For further information contact Alliance Capital Resources, Inc., Jack Sutton (909) 597-2476.
Additional information concerning Nyer Medical Group, Inc. may be found on Nyer’s website http://www.nyermedicalgroup.com
Safe Harbor under the Private Securities Litigation Reform Act of 1995 This press release contains forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. All statements in this release that are not historical facts, including, but not limited to acquiring the remaining 20% interest in D.A.W., Inc., and the Company successfully raising capital necessary to acquire the 20% interest in D.A.W., Inc. are forward-looking statements and are subject to risk and uncertainties. Such risk and uncertainties include, but are not limited to, sustained profitability and any possible change in our core business. Among the factors that change the anticipated results are changes in the capital equity markets. Nyer does not undertake any obligation to update these forward-looking statements.
Nyer Medical Group, Inc.
CONTACT: Jack Sutton of Alliance Capital Resources, Inc., +1-909-597-2476
Web site: http://nyermedicalgroup.com//
